Is Your MedTech Venture Ready for What Regulators, Investors and the Market Will Demand?
The strongest MedTech ventures prepare for all three.
They become:
Investment
Ready
Regulatory
Ready
Commercial
Ready
Three Out of Four U.S. Medical-Device Startups Fail to Achieve Commercial Success.
Promising Technology Is Only the Beginning.
Building a successful MedTech company requires regulatory, investment and commercial decisions that strengthen—not limit—the business.
DevicePoint brings these critical decisions together to build a stronger, more valuable MedTech company.
Every Milestone Should Build Enterprise Value.
Regulatory strategy can preserve—or limit—commercial options. Evidence can strengthen—or weaken—the case for reimbursement and adoption. Financing can increase company value—or simply extend runway.
The strongest ventures don’t simply reach milestones. They emerge from each one with more options, less risk, and a clear path to market.
—
“Value is created long before it’s measured.”
The View Is Different When
You’ve Led the Company.
Michelle Bonn has led four FDA-focused life sciences companies, founding three with international reach and acquiring and selling a fourth.
She’s raised capital, navigated regulatory and commercial pathways across markets, and sat on both sides of the deal table. She understands firsthand the decisions and responsibilities that come with leading an entire enterprise.
She founded DevicePoint to bring MedTech leaders the proven experience that can only come from building, leading, and being accountable for the success of multiple companies.
What Does DevicePoint Do?
DevicePoint helps emerging MedTech companies develop the strategic readiness needed to advance from innovation to successful commercialization.
Through the proprietary DevicePoint Integrated Readiness Framework™, regulatory, reimbursement, investment, market access and commercialization strategy are evaluated together—helping leadership teams identify gaps, reduce avoidable risk and keep critical workstreams aligned.
DevicePoint works as an extension of the leadership team—not simply an outside advisor—helping translate strategy into decisions and action across the entire venture.
Turn Promising Medical Technology
Into a Successful Company.
Regulatory clearance is not the finish line. Neither is financing, reimbursement or launch. Success requires building a company capable of moving through each of them.
DevicePoint brings regulatory, investment and commercial strategy together around one objective:
A stronger MedTech venture designed to succeed.